LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Crizotinib | 0.04 | uM | LJP5 | 2 | A24 | 72 | hr | 1097 | 3345 | 3877 | 0.8626 | 0.8441 |
BT-20 | Crizotinib | 0.04 | uM | LJP5 | 3 | A24 | 72 | hr | 1097 | 3506 | 3925 | 0.8932 | 0.8808 |
BT-20 | Crizotinib | 0.12 | uM | LJP5 | 1 | A23 | 72 | hr | 1097 | 3402 | 3735 | 0.9108 | 0.8970 |
BT-20 | Crizotinib | 0.12 | uM | LJP5 | 2 | A23 | 72 | hr | 1097 | 3762 | 3877 | 0.9701 | 0.9670 |
BT-20 | Crizotinib | 0.12 | uM | LJP5 | 3 | A23 | 72 | hr | 1097 | 3525 | 3925 | 0.8980 | 0.8863 |
BT-20 | Crizotinib | 0.37 | uM | LJP5 | 1 | A22 | 72 | hr | 1097 | 3110 | 3735 | 0.8326 | 0.8031 |
BT-20 | Crizotinib | 0.37 | uM | LJP5 | 2 | A22 | 72 | hr | 1097 | 3363 | 3877 | 0.8673 | 0.8496 |
BT-20 | Crizotinib | 0.37 | uM | LJP5 | 3 | A22 | 72 | hr | 1097 | 3329 | 3925 | 0.8481 | 0.8286 |
BT-20 | Crizotinib | 1.11 | uM | LJP5 | 1 | A21 | 72 | hr | 1097 | 2880 | 3735 | 0.7710 | 0.7264 |
BT-20 | Crizotinib | 1.11 | uM | LJP5 | 2 | A21 | 72 | hr | 1097 | 3053 | 3877 | 0.7873 | 0.7539 |
BT-20 | Crizotinib | 1.11 | uM | LJP5 | 3 | A21 | 72 | hr | 1097 | 3044 | 3925 | 0.7755 | 0.7417 |
BT-20 | Crizotinib | 3.33 | uM | LJP5 | 1 | A20 | 72 | hr | 1097 | 1422 | 3735 | 0.3807 | 0.1580 |
BT-20 | Crizotinib | 3.33 | uM | LJP5 | 2 | A20 | 72 | hr | 1097 | 1492 | 3877 | 0.3848 | 0.1838 |
BT-20 | Crizotinib | 3.33 | uM | LJP5 | 3 | A20 | 72 | hr | 1097 | 1786 | 3925 | 0.4550 | 0.3033 |
BT-20 | Crizotinib | 10 | uM | LJP5 | 1 | A19 | 72 | hr | 1097 | 1066 | 3735 | 0.2854 | -0.0162 |
BT-20 | Crizotinib | 10 | uM | LJP5 | 2 | A19 | 72 | hr | 1097 | 1044 | 3877 | 0.2692 | -0.0269 |
BT-20 | Crizotinib | 10 | uM | LJP5 | 3 | A19 | 72 | hr | 1097 | 1146 | 3925 | 0.2919 | 0.0239 |
BT-20 | BMS345541 | 0.04 | uM | LJP6 | 1 | D06 | 72 | hr | 1097 | 3552 | 3610 | 0.9838 | 0.9811 |
BT-20 | BMS345541 | 0.04 | uM | LJP6 | 2 | D06 | 72 | hr | 1097 | 3691 | 3713 | 0.9939 | 0.9930 |
BT-20 | BMS345541 | 0.04 | uM | LJP6 | 3 | D06 | 72 | hr | 1097 | 3562 | 3696 | 0.9636 | 0.9582 |
BT-20 | BMS345541 | 0.12 | uM | LJP6 | 1 | D05 | 72 | hr | 1097 | 3225 | 3610 | 0.8932 | 0.8728 |
BT-20 | BMS345541 | 0.12 | uM | LJP6 | 2 | D05 | 72 | hr | 1097 | 3343 | 3713 | 0.9002 | 0.8839 |
BT-20 | BMS345541 | 0.12 | uM | LJP6 | 3 | D05 | 72 | hr | 1097 | 3697 | 3696 | 1.0002 | 1.0002 |
BT-20 | BMS345541 | 0.37 | uM | LJP6 | 1 | D04 | 72 | hr | 1097 | 3072 | 3610 | 0.8508 | 0.8206 |
BT-20 | BMS345541 | 0.37 | uM | LJP6 | 2 | D04 | 72 | hr | 1097 | 3131 | 3713 | 0.8431 | 0.8151 |